olivlawolivlaw

olivLaw · US equity research

OSI Systems, Inc. OSIS

Semiconductors & Related Devices · SIC 3674 · Vertical: Semiconductors & Related Devices (SIC 3674)

191.61USD−5.57% · 1 dayClose 05 Nov 2026

OSI Systems designs and manufactures specialized electronic systems and components for critical applications, mainly for security, healthcare and defense. It reported revenue of 1.79 billion USD in fiscal 2026 and a backlog of about 1.9 billion USD, while its fiscal 2027 guidance points to moderate revenue growth, making the company relevant to those following global security demand.

The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).

At the close of 05 Nov 2026, OSI Systems, Inc. (OSIS) stock was 191.61 USD (−5.57% on the day), with market capitalisation 3.0 bn USD, P/E 20.5 on diluted EPS of 9.33 USD over the last 12 months, beta 1.23, 52-week range 191.61–309.68 USD. Latest reported quarter (Q1 2027): revenue of 403.5 m USD (+4.9% YoY), net income of 24.6 m USD (+19.5% YoY), diluted EPS 1.51 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
3.0 bn USD
shares as of 23 Oct 2026
P/E (TTM)
20.5
Diluted EPS TTM 9.33 · TTM to 30 Sept 2026
E/P (TTM)
4.87%
TTM to 30 Sept 2026
Dividend yield
unavailable
Beta (2y)
1.23
Volatility (1y) 42%
52-week range
191.61309.68

Price history

Loading chart…

Technical reading

RSI (14)
41.0
weak (30–45)
Bollinger (20, 2)
190.02 – 205.40
in the lower half of the band · %B 0.10 · band width 7.8%
SMA 50 / 200
199.50 / 235.93
downtrend (price < SMA50 < SMA200)
MACD (12, 26, 9)
-0.08 / -0.18
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month−3.5%−5.9%+2.4 pp—
3 months−19.2%−4.6%−14.6 pp—
6 months−20.5%+0.2%−20.8 pp—
Year to date−24.9%+7.4%−32.3 pp—
1 year−32.0%+8.2%−40.2 pp+11.4%
3 years+75.8%+68.4%+7.4 pp+65.9%
5 years+99.7%+56.5%+43.1 pp—
Max drawdown (1y)
−38.1%
17 Apr 2026 → 05 Nov 2026
Max drawdown (5y)
−38.1%
17 Apr 2026 → 05 Nov 2026
Compound annual growth (5y)
+14.8%
S&P 500 +9.4%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q1 2027 · 30 Sept 2026

Revenue
403.5 m USD
+4.9% YoY
Net income
24.6 m USD
+19.5% YoY
Diluted EPS
1.51
+28.0% YoY
net / operating
6.1% / 8.3%

Quarterly margins

Quarterly statements · USD

Fiscal yearQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Revenue419.8 m444.4 m505.0 m384.6 m464.1 m453.2 m484.1 m403.5 m
Cost of revenue272.7 m294.1 m336.7 m261.4 m312.4 m302.9 m316.1 m279.7 m
Gross profit147.2 m150.3 m168.2 m123.2 m151.6 m150.3 m168.0 m123.8 m
Research & development18.3 m18.6 m18.8 m20.4 m19.8 m19.5 m19.5 m19.4 m
SG&A70.7 m73.2 m74.7 m67.0 m70.2 m71.5 m69.7 m68.7 m
Operating income58.0 m56.2 m73.0 m33.1 m58.8 m53.2 m73.9 m33.6 m
Depreciation & amortisation10.6 m10.6 m10.9 m10.3 m9.6 m9.5 m13.3 m9.0 m
Interest expense8.6 m8.2 m7.2 m7.4 m10.7 m4.0 m4.1 m3.3 m
Pre-tax income49.3 m48.0 m65.8 m25.7 m48.1 m49.2 m69.8 m30.2 m
Income tax11.5 m6.9 m13.1 m5.1 m9.4 m9.0 m14.5 m5.7 m
Net income37.8 m41.1 m52.7 m20.6 m38.7 m40.2 m55.2 m24.6 m
Diluted EPS2.222.403.031.182.222.333.271.51
Operating cash flow52.5 m ≈81.6 m ≈562.0 k17.1 m62.2 m ≈14.5 m ≈182.1 m37.1 m
Capex5.5 m ≈4.5 m ≈6.1 m7.0 m6.7 m ≈7.6 m ≈9.3 m7.7 m
Share repurchases0 ≈0 ≈0——0 ≈124.9 m62.8 m

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 34 percentile of its own 32-quarter history (min 11.8, median 21.9, max 37.7; quarters with earnings only).

Fiscal years

Fiscal year20192020202120222023202420252026
Revenue1.2 bn1.2 bn1.1 bn1.2 bn1.3 bn1.5 bn1.7 bn1.8 bn
Revenue YoY+8.5%−1.4%−1.6%+3.2%+8.0%+20.4%+11.3%+4.3%
Net income64.8 m75.3 m74.0 m115.3 m91.8 m128.2 m149.6 m154.7 m
Net income YoYunavailable+16.1%−1.6%+55.8%−20.4%+39.6%+16.8%+3.4%
Diluted EPS3.464.054.036.455.347.388.718.95
Diluted EPS YoYunavailable+17.1%−0.5%+60.0%−17.2%+38.2%+18.0%+2.8%
net %5.5%6.5%6.5%9.7%7.2%8.3%8.7%8.7%
Free cash flow91.7 m108.1 m122.2 m48.9 m79.0 m-109.6 m73.8 m245.3 m

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2026 · 30 Jun 2026

Cash
359.8 m USD
Financial debt
1.0 bn USD
Net debt
641.2 m USD
Equity
833.0 m USD
Total assets
2.5 bn USD
Debt / equity
1.20x
Current ratio
3.15x
ROE
17.3%
ROA
6.5%
FCF margin
13.7%

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2024
1.5 bn
2025
1.7 bn
2026
1.8 bn

SEC (XBRL)· 21 Aug 2026verified

Cost of revenue
2024
1.0 bn
2025
1.1 bn
2026
1.2 bn

SEC (XBRL)· 21 Aug 2026verified

Gross profit
2024
530.5 m
2025
587.2 m
2026
593.1 m

SEC (XBRL)· 21 Aug 2026verified

Research & development
2024
65.3 m
2025
73.4 m
2026
79.1 m

SEC (XBRL)· 21 Aug 2026verified

SG&A
2024
269.7 m
2025
290.9 m
2026
278.4 m

SEC (XBRL)· 21 Aug 2026verified

Operating income
2024
189.1 m
2025
217.5 m
2026
219.0 m

SEC (XBRL)· 21 Aug 2026verified

Depreciation & amortisation
2024
42.2 m
2025
43.6 m
2026
42.7 m

SEC (XBRL)· 21 Aug 2026verified

EBITDA
2024
231.3 m ≈
2025
261.1 m ≈
2026
261.6 m ≈

SEC (XBRL)· 21 Aug 2026derived

Interest expense
2024
27.8 m
2025
31.4 m
2026
26.2 m

SEC (XBRL)· 21 Aug 2026verified

Pre-tax income
2024
161.2 m
2025
186.1 m
2026
192.7 m

SEC (XBRL)· 21 Aug 2026verified

Income tax
2024
33.1 m
2025
36.5 m
2026
38.0 m

SEC (XBRL)· 21 Aug 2026verified

Net income
2024
128.2 m
2025
149.6 m
2026
154.7 m

SEC (XBRL)· 21 Aug 2026verified

Diluted EPS
2024
7.38
2025
8.71
2026
8.95

SEC (XBRL)· 21 Aug 2026verified

Weighted average diluted shares
2024
17.4 m
2025
17.2 m
2026
17.3 m

SEC (XBRL)· 21 Aug 2026verified

Balance sheet · USD

Cash
2024
95.4 m
2025
106.4 m
2026
359.8 m

SEC (XBRL)· 21 Aug 2026verified

Receivables
2024
648.2 m
2025
837.7 m
2026
764.6 m

SEC (XBRL)· 21 Aug 2026verified

Inventories
2024
397.9 m
2025
407.2 m
2026
415.6 m

SEC (XBRL)· 21 Aug 2026verified

Current assets
2024
1.2 bn
2025
1.4 bn
2026
1.6 bn

SEC (XBRL)· 21 Aug 2026verified

Property, plant & equipment, net
2024
114.0 m
2025
126.7 m
2026
129.9 m

SEC (XBRL)· 21 Aug 2026verified

Goodwill
2024
351.5 m
2025
387.4 m
2026
406.7 m

SEC (XBRL)· 21 Aug 2026verified

Intangibles (excl. goodwill)
2024
139.5 m
2025
183.3 m
2026
192.4 m

SEC (XBRL)· 21 Aug 2026verified

Total assets
2024
1.9 bn
2025
2.2 bn
2026
2.5 bn

SEC (XBRL)· 21 Aug 2026verified

Accounts payable
2024
191.1 m
2025
205.2 m
2026
169.0 m

SEC (XBRL)· 21 Aug 2026verified

Short-term debt
2024
8.2 m
2025
8.1 m
2026
2.5 m

SEC (XBRL)· 21 Aug 2026verified

Long-term debt
2024
129.4 m
2025
463.5 m
2026
998.5 m

SEC (XBRL)· 21 Aug 2026verified

Current liabilities
2024
814.6 m
2025
696.9 m
2026
511.1 m

SEC (XBRL)· 21 Aug 2026verified

Total liabilities
2024
1.1 bn
2025
1.3 bn
2026
1.7 bn

SEC (XBRL)· 21 Aug 2026verified

Equity
2024
863.5 m †
2025
951.1 m †
2026
833.0 m †

SEC (XBRL)· 21 Aug 2026verified

Cash flow · USD

Operating cash flow
2024
-87.5 m
2025
97.6 m
2026
275.9 m

SEC (XBRL)· 21 Aug 2026verified

Capex
2024
22.1 m
2025
23.8 m
2026
30.6 m

SEC (XBRL)· 21 Aug 2026verified

Free cash flow
2024
-109.6 m ≈
2025
73.8 m ≈
2026
245.3 m ≈

SEC (XBRL)· 21 Aug 2026derived

Investing cash flow
2024
-37.6 m
2025
-117.9 m
2026
-68.3 m

SEC (XBRL)· 21 Aug 2026verified

Financing cash flow
2024
144.3 m
2025
30.8 m
2026
46.7 m

SEC (XBRL)· 21 Aug 2026verified

Share repurchases
2024
0
2025
80.4 m
2026
271.9 m

SEC (XBRL)· 21 Aug 2026verified

Computed indicators

Growth

Revenue growth (YoY)
4.3%
computed by olivLawFY 2026
Revenue CAGR 3Y
11.8%
computed by olivLawFY 2023 → FY 2026
Revenue CAGR 5Y
9.3%
computed by olivLawFY 2021 → FY 2026
EBIT growth (YoY)
0.7%
computed by olivLawFY 2026
Net income growth (YoY)
3.4%
computed by olivLawFY 2026
Net income CAGR 3Y
19.0%
computed by olivLawFY 2023 → FY 2026
Net income CAGR 5Y
15.9%
computed by olivLawFY 2021 → FY 2026
EPS growth (YoY)
2.8%
computed by olivLawFY 2026
EPS CAGR 3Y
18.8%
computed by olivLawFY 2023 → FY 2026
EPS CAGR 5Y
17.3%
computed by olivLawFY 2021 → FY 2026
FCF growth (YoY)
232.6%
computed by olivLawFY 2026

Profitability

Gross margin
32.9%
computed by olivLawTTM to 30 Sept 2026
EBITDA margin
14.5%
computed by olivLawTTM to 30 Sept 2026
EBIT margin
12.2%
computed by olivLawTTM to 30 Sept 2026
Net margin
8.8%
computed by olivLawTTM to 30 Sept 2026
FCF margin
14.7%
computed by olivLawTTM to 30 Sept 2026

Returns

ROE
18.4%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROA
6.6%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROIC
12.6%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROCE
11.3%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Payout ratio (EPS)
unavailable
input data missing
Payout ratio (FCF)
unavailable
input data missing

Balance sheet

Net debt
763.3 m USD
computed by olivLawbalance sheet at 30 Sept 2026
Net debt / EBITDA
2.9x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Debt / equity
1.3x
computed by olivLawbalance sheet at 30 Sept 2026
Interest coverage
9.9x
computed by olivLawTTM to 30 Sept 2026

Liquidity

Current ratio
2.9x
computed by olivLawbalance sheet at 30 Sept 2026
Cash ratio
0.4x
computed by olivLawbalance sheet at 30 Sept 2026

Cash

Operating cash flow
295.9 m USD
computed by olivLawTTM to 30 Sept 2026
Capital expenditure
31.2 m USD
computed by olivLawTTM to 30 Sept 2026
Free cash flow
264.7 m USD
computed by olivLawTTM to 30 Sept 2026
FCF conversion
166.7%
computed by olivLawTTM to 30 Sept 2026
Cash conversion
113.4%
computed by olivLawTTM to 30 Sept 2026

Efficiency

Days sales outstanding
159 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Days payables outstanding
61 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026

Market and valuation

Market capitalisation
3.0 bn USD
computed by olivLawbalance sheet at 30 Sept 2026
Enterprise value
3.8 bn USD
computed by olivLawbalance sheet at 30 Sept 2026
Market cap / net income TTM
19.0x
computed by olivLawTTM to 30 Sept 2026
P/E (TTM)
20.5x
computed by olivLawTTM to 30 Sept 2026
Earnings yield
4.9%
computed by olivLawTTM to 30 Sept 2026
P/B
3.8x
computed by olivLawbalance sheet at 30 Sept 2026
P/S
1.7x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
EV/EBITDA
14.5x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
EV/EBIT
17.2x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
EV/Sales
2.1x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
P/FCF
11.4x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
FCF yield
8.8%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Dividend yield
unavailable
no dividend in the structured statements; a missing line is not a confirmed zero
Shareholder yield (distributions)
9.0%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026

4 indicators that do not apply to the sector.

Valuation

olivLaw classification

Neutral profile

Score: 55 / 100

A scoring methodology on indicators and valuation, not investment advice.

Closing price

191.61 USD

05 Nov 2026Source: olivLaw, closing series

Market cap: 3.0 bn USD

Key indicators

Market capitalisation
3.0 bn USD
computed by olivLawbalance sheet at 30 Sept 2026
P/E (TTM)
20.5x
computed by olivLawTTM to 30 Sept 2026
P/B
3.8x
computed by olivLawbalance sheet at 30 Sept 2026
EV/EBITDA
14.5x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROE
18.4%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Net margin
8.8%
computed by olivLawTTM to 30 Sept 2026
Revenue growth (YoY)
4.3%
computed by olivLawFY 2026
Dividend yield
unavailable
no dividend in the structured statements; a missing line is not a confirmed zero

Coverage and freshness

34/37 reporting lines present
Latest full fiscal year: 2026
Latest reported period: 30 Sept 2026
Latest balance sheet date: 30 Sept 2026
Share count (cover of the latest filing), as of: 23 Oct 2026
Source: SEC (XBRL)published 29 Oct 2026
verified 2643derived 154

Score by group

  • Balance sheet50
  • Returns100
  • Quality34
  • Growth39
  • Valuation84

Estimated value range

Low
141.14
USD per share
Mid
350.26
USD per share
High
485.09
USD per share
Price: 191.61 USD
The price is within the range
Potential to the central value: 82.8% (value / price − 1)
Margin of safety: 45.3% (1 − price / value)
Agreement between methods: low · 3 methods used · 2 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 95.34 – 1,428.05 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)271.49 – 485.09 (Mid 350.26)
    WACC 8.2% · starting FCFF 282.5 m USD · terminal value share of EV 77%
    The WACC × g sensitivity gives the method's bounds; these are not probabilities.
    Reverse DCF: starting growth implied by the price (fading linearly to terminal growth, everything else fixed): -9.8%
  • Peers: EV/Sales141.14 – 1,428.05 (Mid 537.75)
    27 companies used · median multiple 5.1x · quartiles 1.7x – 12.9x
    AAOI, ADI, AMAT, AMD, AMKR, ARRY, AVGO, AXTI, FSLR, GCTS, INTC, LEDS, LSCC, MCHP, MRVL, MTSI, MU, NVDA, NXPI, ON, PENG, Q, SPCB, SUNE, TE, TXN, TYGO
  • Peers: EV/EBITDA95.34 – 288.63 (Mid 170.47)
    10 companies used · median multiple 13.2x · quartiles 8.7x – 20.3x
    AMAT, AMKR, FSLR, MCHP, MU, NVDA, NXPI, ON, PENG, SPCB
Multiple comparisons use the SIC vertical: Semiconductors & Related Devices (SIC 3674)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Neutral profile · Score 55/100

FactorValueScoreWeight used
Gross margin · Quality32.9%0 (on a fixed band)11%
EBIT margin · Quality12.2%51 (vs peers)9%
FCF margin · Quality14.7%59 (on a fixed band)9%
Revenue CAGR 3Y · Growth11.8%47 (on a fixed band)17%
Revenue growth (YoY) · Growth4.3%24 (vs peers)9%
Net debt / EBITDA · Balance sheet2.9x0 (vs peers)6%
Current ratio · Balance sheet2.9x100 (on a fixed band)6%
EV/Sales · Valuation2.1x71 (vs peers)17%
FCF yield · Valuation8.8%100 (on a fixed band)13%
Shareholder yield (distributions) · Returns9.0%100 (on a fixed band)4%

Score groups

  • Balance sheet50/100 · 2/2 factors with a value
  • Growth39/100 · 2/2 factors with a value
  • Quality34/100 · 3/3 factors with a value
  • Returns100/100 · 1/1 factors with a value
  • Valuation84/100 · 2/2 factors with a value

Memo

OSI SYSTEMS, INC. (OSIS). Latest full fiscal year: 2026; data up to 2026-09-30.

Figures computed from the financial statements: revenue 1.8 bn USD in 2026; YoY growth 4.3%; net margin 8.8%; ROE 18.4%; net debt/EBITDA 2.9x.

The estimated value range is 141.14–485.09 USD per share (median of 3 methods, agreement: low); assumptions are illustrative. Against the central value of 350.26 USD, the price of 191.61 USD leaves a potential of 82.8% (value / price − 1) and a margin of safety of 45.3% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

olivLaw score 55/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Not investment advice.

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • Current ratio: 2.9x
  • EV/Sales: 2.1x
  • FCF yield: 8.8%
  • Shareholder yield (distributions): 9.0%

What contradicts it

  • Gross margin: 32.9%
  • Revenue growth (YoY): 4.3%
  • Net debt / EBITDA: 2.9x
  • The valuation methods diverge

Versus the vertical median

Semiconductors & Related Devices (SIC 3674) · same industry (4-digit SIC) · compared with 39 companies

Multiples and returns vs the median

P/E
20.5x
vertical median 37.2x
below median (−44.8%)
EV/EBITDA
14.5x
vertical median 15.6x
below median (−7.4%)
P/S
1.7x
vertical median 7.3x
below median (−77.0%)
P/B
3.8x
vertical median 4.7x
below median (−18.1%)
ROE
18.4%
vertical median 12.6%
above median (+46.1%)
Net margin
8.8%
vertical median 11.5%
below median (−23.5%)
EBIT margin
12.2%
vertical median 11.2%
above median (+8.1%)
Revenue YoY
4.3%
vertical median 24.0%
below median (−82.3%)
Net debt/EBITDA
2.9x
vertical median 0.1x
above median (+2,242.4%)
Dividend yield
—
vertical median 0.8%

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
NVDANvidia Corp4,376.6 bn23.0117.2%63.7%+65.5%+3% / +288%
AVGOBroadcom Inc.1,391.7 bn37.244.2%42.9%+23.9%−28% / +215%
MUMicron Technology, Inc.742.7 bn8.888.3%63.8%+256.3%+178% / +762%
AMDAdvanced Micro Devices, Inc663.3 bn88.011.8%16.8%+34.3%+86% / +234%
INTCIntel Corporation277.7 bn—-10.9%-20.1%−0.5%+29% / +17%
TXNTexas Instruments Inc254.2 bn36.039.7%34.3%+13.0%+65% / +82%
AMATApplied Materials Inc253.4 bn27.541.1%30.1%+4.4%+27% / +113%
ADIAnalog Devices Inc174.9 bn42.812.2%29.8%+16.9%+36% / +97%
MRVLMarvell Technology, Inc117.1 bn44.116.5%27.9%+42.1%+49% / +140%
NXPINXP Semiconductors N.V.61.6 bn19.229.2%23.4%−2.7%+25% / +20%
MPWRMonolithic Power Systems, Inc.55.2 bn62.425.1%23.9%+26.4%+22% / +106%
MCHPMicrochip Technology Inc35.3 bn47.212.6%15.0%+7.1%+21% / −22%
ALABAstera Labs, Inc.31.4 bn71.628.2%29.6%+115.1%+14% / unavailable
IMOSChipMOS TECHNOLOGIES INC.29.7 bn676.05.6%6.3%−0.8%+55% / +64%
ONOn Semiconductor Corp24.5 bn36.68.9%10.8%−15.3%+25% / −12%
QQnity Electronics, Inc.23.0 bn38.97.6%11.5%+9.7%+36% / unavailable
CRDOCredo Technology Group Holding Ltd21.1 bn40.030.7%33.8%+205.7%−37% / +527%
FSLRFirst Solar, Inc.21.0 bn11.318.7%37.1%+24.1%−28% / +24%
MTSIMACOM Technology Solutions Holdings, Inc.14.5 bn60.917.2%20.7%+32.6%+9% / +127%
LSCCLattice Semiconductor Corp13.9 bn301.74.2%5.5%unavailable+40% / +67%
AMKRAmkor Technology, Inc.7.6 bn12.313.6%8.3%+6.2%−16% / +8%
CRUSCirrus Logic, Inc.5.5 bn13.919.5%20.2%+5.3%−8% / +45%
AAOIApplied Optoelectronics, Inc.4.3 bn—-2.3%-4.4%+82.8%+75% / +254%
OSISOsi Systems, Inc.3.0 bn20.518.4%8.8%+4.3%−32% / +76%
AXTIAxt Inc2.4 bn1,792.40.8%3.2%−11.1%+243% / +1,745%

1- and 3-year price returns: for OSIS from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
131.48
Total return -31% · Per year -31%
231.69
Total return 21% · Per year 21%
347.95
Total return 82% · Per year 82%
3 years
146.99
Total return -23% · Per year -8%
289.54
Total return 51% · Per year 15%
474.60
Total return 148% · Per year 35%
5 years
164.32
Total return -14% · Per year -3%
361.84
Total return 89% · Per year 14%
647.34
Total return 238% · Per year 28%
What moves the 3-year price the most
  • Exit P/E± 72.39
  • Net margin± 50.67
  • Annual revenue growth± 38.88
  • Annual dilution± 4.26

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

Possibly outdated: the newest document it read is from 21 Aug 2026; since then the company filed 8-K (29 Oct 2026 · results), 10-Q (29 Oct 2026).

In brief

OSI Systems designs and manufactures specialized electronic systems and components for critical applications, mainly for security, healthcare and defense. It reported revenue of 1.79 billion USD in fiscal 2026 and a backlog of about 1.9 billion USD, while its fiscal 2027 guidance points to moderate revenue growth, making the company relevant to those following global security demand.

SWOT

Strengths

  • Vertical integration gives control over costs and deliveries, and expertise in critical systems is recognized by institutional customers 1.
  • The company reported record operating cash flow and a substantial backlog 2.
  • Global presence and manufacturing capacity in several countries help the company serve international customers 1.

Weaknesses

  • Revenue is concentrated in the Security division, and delays in large projects can weigh on quarterly results 12.
  • The Healthcare division performed weaker in fiscal 2026, with lower revenues 1.
  • The company depends on large government customers that can modify or terminate contracts more easily than commercial customers 1.

Opportunities

  • New air defense and airspace surveillance programs could open additional demand for high-power radio frequency systems 1.
  • Demand for cloud software platforms that integrate inspection data could grow as customers modernize their procedures 1.
  • Population ageing and healthcare infrastructure growth in emerging regions could support demand for remote monitoring 1.

Threats

  • Trade tensions and tariffs could raise material costs or reduce revenues 1.
  • Payer pressure and consolidation among healthcare buyers could push product prices down 1.
  • A failure of detection systems could expose the company to product and professional liability claims 1.

Risks

  • Detection liabilityhigh

    If an inspection system fails to detect a threat, the company could face liability claims, and insurance coverage might be insufficient 1.

  • Dependence on government contractshigh

    Loss of large institutional customers or non-renewal of key contracts could weigh on reputation and revenues 1.

  • Conflict-related delaysmedium

    If tensions in the Middle East escalate, shipments and acceptances could be delayed, affecting quarterly revenues 12.

  • Currency riskmedium

    Exchange rate fluctuations could affect results, since a significant part of sales is made outside the United States 1.

  • Government budget disruptionslow

    Delays in approving the US federal budget could postpone procurements and contract awards 1.

Investment thesis

What would need to be true (bull case)

  • If the fiscal 2027 guidance is delivered, the company could show steady profit growth supported by a large backlog and solid cash flow 2.
  • Security demand could stay strong amid geopolitical tensions, and large international contracts could provide multi-year visibility 1.
  • If vertical integration and operating efficiency hold, the company could keep attractive margins even under competitive pressure 12.

What would break the thesis

  • If Middle East delays extend, quarterly revenues could fall short of expectations even though orders remain in backlog 12.
  • If the Healthcare and Optoelectronics divisions do not improve, the company could depend too heavily on the Security division 1.
  • Pricing pressure and component cost increases could reduce margins if competition intensifies 1.

What to watch

  • Timing of delayed Middle East deliveries and their conversion from backlog into revenueQ1 2027
  • Delivery against fiscal 2027 guidance for revenues and non-GAAP earnings per sharefiscal 2027
  • Revenue and operating margin trends in the Healthcare divisionfiscal 2027
  • New government security contracts and renewal of key existing contractsnext 10-K

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

Possibly outdated: the newest document it read is from 21 Aug 2026; since then the company filed 8-K (29 Oct 2026 · results), 10-Q (29 Oct 2026).

The business

OSI Systems, Inc. is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications, selling into homeland security, healthcare, defense and aerospace markets 1. It operates through three divisions: Security, Optoelectronics and Manufacturing, and Healthcare 1. The company describes vertical integration, lower production costs and direct control over components as its main competitive advantage 1.

In fiscal 2026 revenues rose to approximately 1.8 billion USD, driven by the Security and Optoelectronics divisions and partly offset by lower Healthcare revenues 1. Operating cash flow increased significantly, supported by improved working capital and collections on large Security projects 1. The company reported record non-GAAP earnings per share in the fourth quarter 2.

Customers include government agencies, airports, seaports, hospitals and military contractors, and the company serves customers in over 170 countries 2. Some large contracts, particularly international Security contracts, have revenue recognition schedules that can vary from one year to the next 1.

Segments

Security

The Security division supplies inspection and security systems, including X-ray, computed tomography and radiation detection technologies, along with turnkey screening solutions and software platforms 1. It accounted for 70% of consolidated revenues in fiscal 2026 1.

Optoelectronics and Manufacturing

The division makes optoelectronic devices and electronics manufacturing services for OEM customers in aerospace, defense and medical markets 1. It accounted for 21% of consolidated revenues in fiscal 2026 1.

Healthcare

The Healthcare division develops patient monitoring, cardiology and remote monitoring systems for hospitals and clinics 1. It accounted for 9% of consolidated revenues in fiscal 2026 1.

Market context

Demand for inspection equipment is influenced by terrorist threats, drug and human trafficking, border security and new government mandates, and the international market keeps expanding as countries upgrade their security infrastructure 1. In healthcare, population ageing and infrastructure growth in developing regions support long-term demand, while cost pressures limit hospital budgets 1.

Fiscal 2027 guidance calls for revenues between 1.875 and 1.930 billion USD and non-GAAP earnings per share between 11.13 and 11.49 USD 2. If delivery delays caused by Middle East conflicts continue to shift the revenue timing, quarterly results could remain volatile compared with the annual guidance 2.

Trends

  • Geopolitical demand for securitytailwind

    Regional conflicts and terrorist threats could increase government spending on inspection and detection systems, which supports demand for Security division products 1.

  • Middle East conflict delaysheadwind

    Conflicts in the Middle East delayed shipments, acceptance procedures and projects in the fourth quarter of fiscal 2026, and the company says these delays do not reflect order cancellations 12.

  • Pressure on healthcare budgetsheadwind

    Hospitals face higher operating costs and more expensive credit, which could reduce capital spending on medical equipment 1.

  • Memory component shortagesmixed

    Global demand for memory from data center and AI infrastructure has tightened supply and raised costs for certain components, which could affect execution 1.

Competitive position

The company faces aggressive competition in all three divisions, based on product performance, government certification, price and local presence 1. In optoelectronics and electronics manufacturing, competition turns on expertise, quality and the ability to provide integrated services from design to production 1.

The company warns that it may have to lower product prices to stay competitive and that new technologies could reduce the value of existing product lines 1.

  • Security and inspection competitors

    The sources do not name individual competitors, only general competition in the Security division 1.

  • Patient monitoring competitors

    The sources describe competition in patient monitoring and cardiology without naming companies 1.

  • Electronics manufacturing service providers

    The sources refer to competition in electronics manufacturing without naming companies 1.

  • Other optoelectronics suppliers

    The sources mention competition in optoelectronics without naming companies 1.

News & filings

In the press

The latest news item in our archive is from 27 Aug 2026; the newest SEC filing is from 29 Oct 2026. The press archive comes from the RSS feeds we follow and does not necessarily cover the latest event — the filings alongside do.

SEC filings

Sources

  1. [1] Form 10-K, fiscal year ended 2026-06-30 · SEC / OSI Systems, Inc. · 21 Aug 2026
  2. [2] Form 8-K, results release (exhibit 99.1) · SEC / OSI Systems, Inc. · 20 Aug 2026

Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.

OSI Systems, Inc. (OSIS): stock, results, valuation and forecast · olivLaw